Skip to content

Clinical trials

Completed Phase 1 Burkitt Lymphoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Burkitt Lymphoma Phase: Phase 1 Status: Completed Clear all

177 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200013
20016
200213
20036
200412
20058
200610
20079
20084
20098
20105
20114
20123
20138
20143
20167
20171
20182
20193
20204
20211
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed177

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)53
National Institutes of Health Clinical Center (CC)9
Memorial Sloan Kettering Cancer Center7
Case Comprehensive Cancer Center5
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins5
City of Hope Medical Center4
Mayo Clinic4
Northwestern University4
Regeneron Pharmaceuticals4
Children's Oncology Group3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Burkitt Lymphoma177
Lymphoma, Large B-Cell, Diffuse144
Lymphoma, Follicular141
Lymphoma, Mantle-Cell140
Precursor Cell Lymphoblastic Leukemia-Lymphoma139
Lymphoma, Non-Hodgkin131
Leukemia, Lymphocytic, Chronic, B-Cell129
Lymphoma, B-Cell, Marginal Zone129
Lymphoma, Large-Cell, Immunoblastic125
Hodgkin Disease101

Trials

Showing 1 to 25 of 177. Each trial links to its page on Pharma Observatory.

77 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.